Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall SurvivalYu Sawada, Tetsuya Nakatsura, Toshimitsu Kuronuma et al.|Clinical Cancer Research|2012Cited by 299
Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English editionMasato Nagino, Itaru Endo, Satoshi Hirano et al.|Journal of Hepato-Biliary-Pancreatic Sciences|2020Cited by 235